Skip to main content
logo
Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
226.78
-2.97 (-1.29%)
Oct 23, 2026, 12:54 PM EDT - Market open

Danaher Operating Metrics

Period EndingSep 30, 2026Jun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Oct 1, 2021Sep 30, 2021Jul 2, 2021Jun 30, 2021Apr 2, 2021Mar 31, 2021Dec 31, 2020Oct 2, 2020Sep 30, 2020Jul 3, 2020Jun 30, 2020Apr 3, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Sep 27, 2019Jun 30, 2019Jun 28, 2019Mar 31, 2019Mar 29, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018
Recurring Revenue
5.40B5.20B5.03B5.32B5.02B4.97B4.82B5.11BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-UpgradeUpgradeUpgrade-UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Recurring Revenue Growth
7.61%4.63%4.46%4.29%5.02%5.99%0.44%83.90%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-UpgradeUpgradeUpgrade-UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade

Revenue by Segment

Period EndingSep 30, 2026Jun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Oct 1, 2021Sep 30, 2021Jul 2, 2021Jun 30, 2021Apr 2, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
10.49B10.07B9.91B9.94B9.86B9.76B9.71B9.79BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Diagnostics Growth
6.36%3.16%2.06%1.57%-0.08%0.01%-0.20%2.19%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Life Sciences
7.57B7.49B7.39B7.33B7.28B7.27B7.26B7.33BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Life Sciences Growth
3.91%3.05%1.75%0.07%0.75%1.68%1.21%2.63%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Biotechnology
7.56B7.55B7.48B7.29B7.13B6.98B6.85B6.76BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Biotechnology Growth
6.00%8.08%9.22%7.90%7.22%4.86%0.22%-5.76%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade

Operating Income by Segment

Period EndingSep 30, 2026Jun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Oct 1, 2021Sep 30, 2021Jul 2, 2021Jun 30, 2021Apr 2, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
2.42B2.47B2.61B2.65B2.56B2.51B2.51B2.63BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Diagnostics Growth
-5.62%-1.71%3.70%0.95%-7.44%-6.69%-1.80%9.10%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Biotechnology
2.11B1.98B1.96B1.86B1.83B1.87B1.74B1.63BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Biotechnology Growth
15.01%5.99%12.41%14.71%19.50%19.87%6.29%-14.88%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Life Sciences
1.06B1.03B544.00M520.00M560.00M373.00M845.00M879.00MUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Life Sciences Growth
90.00%175.34%-35.62%-40.84%-24.12%-63.29%-24.76%-27.30%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade
Other
-367.00M-347.00M-347.00M-344.00M-340.00M-337.00M-334.00M-326.00MUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade

Revenue by Geography

Period EndingSep 30, 2026Jun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Oct 1, 2021Sep 30, 2021Jul 2, 2021Jun 30, 2021Apr 2, 2021Mar 31, 2021Dec 31, 2020Oct 2, 2020Sep 30, 2020Jul 3, 2020Jun 30, 2020Apr 3, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Sep 27, 2019Jun 30, 2019Jun 28, 2019Mar 31, 2019Mar 29, 2019
North America
10.45B10.29B10.25B10.36B10.45B10.25B10.25B10.30BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-Upgrade------
North America Growth
-0.06%0.38%0.07%0.59%3.39%-4.30%-8.55%-11.20%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-Upgrade------
Western Europe
6.29B6.19B6.16B5.94B5.86B5.66B5.48B5.46BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-Upgrade------
Western Europe Growth
7.25%9.34%12.45%8.81%10.41%1.53%-8.17%-14.04%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-Upgrade------
High Growth Markets
2.03B1.96B1.62B2.03B1.76B1.70B1.54B1.89BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-Upgrade-UpgradeUpgradeUpgradeUpgradeUpgrade
High Growth Markets Growth
15.05%15.38%5.66%7.48%0.57%0.06%--0.72%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-Upgrade-UpgradeUpgradeUpgradeUpgradeUpgrade
Other Developed Markets
1.24B1.26B1.26B1.25B1.25B1.23B1.23B1.25BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-Upgrade------
Other Developed Markets Growth
-0.56%2.20%2.44%-0.08%-1.51%-5.03%-7.68%-9.21%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-Upgrade------

Operating Expense Breakdown

Period EndingSep 30, 2026Jun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Oct 1, 2021Sep 30, 2021Jul 2, 2021Jun 30, 2021Apr 2, 2021Mar 31, 2021Dec 31, 2020Oct 2, 2020Sep 30, 2020Jul 3, 2020Jun 30, 2020Apr 3, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Sep 27, 2019Jun 30, 2019Jun 28, 2019
Selling, General, and Administrative
8.12B7.95B8.24B8.24B8.23B8.30B7.81B7.76BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-UpgradeUpgradeUpgrade-UpgradeUpgrade
Selling, General, and Administrative Growth
-1.40%-4.24%5.47%6.13%5.93%5.66%-4.53%-8.94%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-UpgradeUpgradeUpgrade-UpgradeUpgrade
Research and Development
1.67B1.62B1.61B1.60B1.60B1.61B1.60B1.58BUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-UpgradeUpgradeUpgrade-UpgradeUpgrade
Research and Development Growth
4.24%0.50%0.69%0.88%3.42%1.52%-0.93%-5.21%UpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgradeUpgrade-Upgrade-UpgradeUpgradeUpgrade-UpgradeUpgrade